Clinical Trial Detail

NCT ID NCT02561455
Title Rollover Study for Subjects Who Have Participated in an Astellas Sponsored ASP2215 Trial
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Astellas Pharma Global Development, Inc.
Indications

Advanced Solid Tumor

acute myeloid leukemia

Therapies

Gilteritinib

Age Groups: adult

No variant requirements are available.